Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 80Breast Neoplasms 52Prostatic Neoplasms 42Lung Neoplasms 29Multiple Myeloma 28Parkinson Disease 4, Autosomal Dominant Lewy Body 22Neoplasms 21Neoplasm Metastasis 20Leukemia, Lymphocytic, Chronic, B-Cell 19Colorectal Neoplasms 19Carcinoma, Renal Cell 19Ovarian Neoplasms 17Squamous Cell Carcinoma of Head and Neck 13Recurrence 12Leukemia, Myeloid, Acute 12Urinary Bladder Neoplasms 11Small Cell Lung Carcinoma 11Pancreatic Neoplasms 11Myasthenia Gravis 11Endometrial Neoplasms 11Triple Negative Breast Neoplasms 10Stomach Neoplasms 9Non-Muscle Invasive Bladder Neoplasms 9Nasopharyngeal Carcinoma 9Lymphoma, Large B-Cell, Diffuse 9Fallopian Tube Neoplasms 9Lymphoma, Non-Hodgkin 8Lymphoma, Follicular 8Carcinoma 8Burkitt Lymphoma 8

Interventions

Standard of Care 1Specimen Handling 1Respiratory Physiological Phenomena 1Practice Guidelines as Topic 1Platinum 1Magnetic Resonance Spectroscopy 1Etoposide 1Cisplatin 1Carboplatin 1Bleomycin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Endodermal Sinus Tumor × 30 days × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡